AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Have a cold? Fever? Sinus infection? Your primary-care provider might not give you a prescription for an antibiotic. Here's ...

Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.

Scientists develop self-propelling nanoparticles that can physically pierce and eliminate drug-resistant bacteria in eye infections, showing success in initial animal studies.

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...

The OECD report highlighted the need for targeted policies to reduce the impact of AMR and noncommunicable diseases and ...

Alan W. Dunton, MD, Chief Medical Advisor of Recce Pharmaceuticals, added, "We are thrilled to see such robust clinical ...

Antibiotics are a double-edged sword—they ... Bacterial cells differ fundamentally in their structure from animal and human cells. For example, bacteria have a rigid cell wall, whereas human ...

Antibiotics are ineffective against viral infections like human metapneumovirus (HMPV). HMPV affects the respiratory system, and antibiotics, designed to target bacteria, won't help. Misusing ...

In this context, the use of new antibiotic agents (i.e., linezolid, daptomycin and tigecycline) and the optimization of the pharmacodynamic targets of classic antibiotics (i.e., carbapenems ...